• Home Study Details

  • Home / Learn / Home Study CE / Home Study Details


Effective Use of Morbidity- and Mortality-Reducing Agents in Heart Failure

Program Type

OnDemand

Credits

1.25 Contact Hour(s)

Release Date

Friday, January 15, 2021

Offline Date:

Sunday, January 15, 2023

ACPE Expiration Date

Saturday, July 15, 2023

Target Audience

Nurse, Pharmacist

Cost

$4.00

  • Overview

    This session seeks to explore the role of the pharmacist in the management of patients with heart failure. Approximately 25% of hospitalized heart failure patients are readmitted within the first 30 days, often due to medication nonadherence, inadequate understanding of the disease and/or treatment, and the inability to recognize key signs of exacerbation. By categorizing medications as mortality and morbidity reducing agents, this session seeks to assist the pharmacist in exploring medications commonly used in the treatment of heart failure. Notable clinical trials are used as the foundation for best management practices for heart failure patients.

    Handouts

    Slide Document:   20178H01_2pp.pdf
    Slide Document:   20178H01_6pp.pdf

    Financial Support By

    PharmCon
  • Nurse

    Describe the compensatory mechanisms that lead to cardiac remodeling and symptoms of heart failure
    Categorize medications as mortality- and/or morbidity-reducing agents for heart failure
    Recognize notable results of clinical trials that serve as the basis for the current management of heart failure.
    Identify the role of angiotensin receptor/neprilysin inhibitors (ARNIs) in heart failure.


    Pharmacist

    Describe the compensatory mechanisms that lead to cardiac remodeling and symptoms of heart failure
    Categorize medications as mortality- and/or morbidity-reducing agents for heart failure
    Recognize notable results of clinical trials that serve as the basis for the current management of heart failure.
    Identify the role of angiotensin receptor/neprilysin inhibitors (ARNIs) in heart failure.

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-20-178-H01-N

    Pharmacist 0798-0000-20-178-H01-P

    ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

 

©2015 PharmCon All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.